Use of Risperdal Consta during Pregnancy: Report of Four Cases with a Literature Review.
- Author:
Sung Wan KIM
1
;
Seung Hyun LEE
;
Yo Han LEE
;
Woo Young PARK
;
Jae Min KIM
;
Il Seon SHIN
;
Su Jin YANG
;
Dong Seok YANG
;
Jin Sang YOON
Author Information
1. Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea. jsyoon@chonnam.ac.kr
- Publication Type:Case Report
- Keywords:
Schizophrenia;
Risperdal Consta;
Pregnancy;
Antipsychotic
- MeSH:
Antipsychotic Agents;
Humans;
Pregnancy;
Psychotic Disorders;
Risperidone;
Schizophrenia
- From:Korean Journal of Psychopharmacology
2008;19(3):163-167
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Risperdal Consta is the first long-acting intramuscular formulation of an atypical antipsychotic. It is frequently used to treat schizophrenia, but its safety for use during pregnancy has not been established. We report four cases of patients with schizophrenia or schizoaffective disorder who took Risperdal Consta during pregnancy. None of the babies born from these four patients had any congenital malformation and all exhibited healthy postnatal development. This paper presents the rationale for the use of antipsychotics including Risperdal Consta during pregnancy and the related problems through a literature review. This serial case report contributes to the body of knowledge regarding the use of antipsychotics during pregnancy.
